ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 145 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $248,000 | -63.6% | 37,000 | -65.4% | 0.01% | -56.2% |
| Q2 2022 | $681,000 | +37.3% | 107,000 | 0.0% | 0.02% | +60.0% |
| Q1 2022 | $496,000 | -64.8% | 107,000 | +603.9% | 0.01% | -65.5% |
| Q1 2015 | $1,408,000 | +8.1% | 15,200 | -52.8% | 0.03% | -3.3% |
| Q4 2014 | $1,302,000 | +50.0% | 32,200 | -9.3% | 0.03% | +36.4% |
| Q3 2014 | $868,000 | +113.3% | 35,500 | +38.1% | 0.02% | +100.0% |
| Q2 2014 | $407,000 | +7.7% | 25,700 | +2.8% | 0.01% | 0.0% |
| Q1 2014 | $378,000 | – | 25,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $20,735,000 | 8.65% |
| Altium Capital Management LP | 2,496,524 | $11,584,000 | 3.88% |
| Deep Track Capital, LP | 6,000,000 | $27,840,000 | 1.78% |
| Paradigm Biocapital Advisors LP | 1,157,246 | $5,370,000 | 1.42% |
| Monaco Asset Management SAM | 419,262 | $1,945,000 | 0.77% |
| Rhenman & Partners Asset Management AB | 981,582 | $4,555,000 | 0.45% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,713,176 | $12,589,000 | 0.39% |
| Bellevue Group AG | 4,299,164 | $19,948,000 | 0.23% |
| WASATCH ADVISORS LP | 8,147,380 | $37,804,000 | 0.19% |
| Telemetry Investments, L.L.C. | 17,500 | $81,000 | 0.13% |